Not enough history yet — the model records AHR's score after each daily run, and the chart appears once a few days have accumulated.
AHR at a glance
Same audited fundamentals as the score, unless a card says otherwise.
Analyst estimate revisions
| 30-day change | +0.0% |
|---|---|
| 90-day change | +15.1% |
| Forward EPS estimate | $0.99 |
Over the last 90 days, what analysts expect AHR to earn is materially higher (+15.1%). The estimate is derived from price and forward P/E captured at the same instant, so a moving share price does not move this number — only a changed forecast does.
Estimates move both ways and are not part of the Bull Rankings score. Biggest movers →
Math only: excludes commissions, slippage and gap risk. Inputs stay in your browser.
American Healthcare REIT, Inc. (AHR): score, valuation & FAQ
American Healthcare REIT, Inc. (AHR) is a REIT - Healthcare Facilities company. As a bank, insurer or REIT it runs on a different financial model from the rest of the market, so Bull Rankings grades it on a sector-appropriate card — price-to-book, dividend yield, payout ratio and cash-flow coverage — rather than the 0–100 quality-growth score used elsewhere. The read below is a transparent screen, not a buy recommendation.
Its strongest graded signals are D/E (A).
Is AHR a good stock to buy?
Bull Rankings grades AHR on a sector-appropriate card — price-to-book, dividend yield, payout and cash-flow coverage — rather than a single quality-growth score. That is driven by D/E (A). A score is a quantitative screen of American Healthcare REIT, Inc.'s fundamentals, not personalised financial advice — weigh it against your own time horizon and risk tolerance, and read the risk factors below before acting.
How does Bull Rankings grade AHR?
As a bank, insurer or REIT, AHR isn't given a quality-growth score — signals like free cash flow, debt-to-equity and P/E don't translate cleanly to a balance-sheet business. Instead it's graded on a sector-appropriate card: price-to-book, dividend yield, payout ratio and operating-cash-flow coverage, where it rates strongest on D/E (A).
Is AHR overvalued or undervalued?
We don't publish a discounted-cash-flow value for AHR, and not because the business is unprofitable. For a lender, insurer or property trust, "free cash flow" measures balance-sheet growth rather than owner earnings — loan originations and repayments run through operating cash flow — so discounting it would produce a confident-looking number with nothing behind it. AHR is judged on book value, return on equity and income cover instead, which is what the financial-strength card shows.
What are the main risks of investing in AHR?
Net margin 4.8% is thin — operating leverage cuts both ways; input-cost inflation or pricing pressure hits the bottom line first. ROE 4% is below the long-run sustainable threshold of ~10% — capital efficiency would need to improve for the equity base to compound at the market rate.
New to these metrics? See the guides and the methodology.